Cargando…

Diabetes duration and obesity matter in autologous mesenchymal stem/stromal cell transplantation in type 2 diabetes patients

Detalles Bibliográficos
Autores principales:	Lee, Joonyub, Yoon, Kun‐Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847146/ https://www.ncbi.nlm.nih.gov/pubmed/34837356 http://dx.doi.org/10.1111/jdi.13721

Ejemplares similares

Type 2 diabetes mellitus duration and obesity alter the efficacy of autologously transplanted bone marrow‐derived mesenchymal stem/stromal cells
por: Nguyen, Liem Thanh, et al.
Publicado: (2021)

β cell replacement therapy for the cure of diabetes
por: Lee, Joonyub, et al.
Publicado: (2022)

Influence of type 2 diabetes and obesity on adipose mesenchymal stem/stromal cell immunoregulation
por: Mahmoud, Marwa, et al.
Publicado: (2023)

Mesenchymal Stem Cells for the Treatment of Diabetes
por: Pileggi, Antonello
Publicado: (2012)

Long-term efficacy of autologous bone marrow mesenchymal stromal cells for treatment of knee osteoarthritis
por: Lamo-Espinosa, José María, et al.
Publicado: (2021)

Opening the Precision Diabetes Care through Digital Healthcare
por: Lee, Joonyub, et al.
Publicado: (2023)

Fighting the uphill battle to cure type 1 diabetes
por: Lee, Eun Young, et al.
Publicado: (2021)

Transition of mesenchymal stem/stromal cells to endothelial cells
por: Crisan, Mihaela
Publicado: (2013)

Mesenchymal stromal cells enhance the engraftment of hematopoietic stem cells in an autologous mouse transplantation model
por: Fernández-García, María, et al.
Publicado: (2015)

A Future for Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes
por: van Megen, Kayleigh M., et al.
Publicado: (2018)

Risk of developing chronic kidney disease in young-onset Type 2 diabetes in Korea
por: Lee, Joonyub, et al.
Publicado: (2023)

Encapsulation of Mesenchymal Stem Cells: Dissecting the Underlying Mechanism of Mesenchymal Stem Cell Transplantation Therapy
por: Kin, Kyohei, et al.
Publicado: (2020)

A proteomic approach to obesity and type 2 diabetes
por: López-Villar, Elena, et al.
Publicado: (2015)

Allogeneic vs. autologous mesenchymal stem/stromal cells in their medication practice
por: Li, Chenghai, et al.
Publicado: (2021)

Diabetes Therapy Podcast Collection: Language Matters in Diabetes
por: Kalra, Sanjay, et al.
Publicado: (2021)

Kidney transplant tolerance associated with remote autologous mesenchymal stromal cell administration
por: Casiraghi, Federica, et al.
Publicado: (2019)

Commentary: Autologous retinal transplantation for macular hole
por: Babu, Naresh, et al.
Publicado: (2022)

Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing–Remitting Multiple Sclerosis Patients
por: Bertolotto, Antonio, et al.
Publicado: (2020)

Gene Network Analysis for Osteoporosis, Sarcopenia, Diabetes, and Obesity in Human Mesenchymal Stromal Cells
por: Jin, Yilan, et al.
Publicado: (2022)

Mesenchymal Stem/Stromal Cells in Organ Transplantation
por: Deo, Dayanand, et al.
Publicado: (2022)

Immune response after autologous hematopoietic stem cell transplantation in type 1 diabetes mellitus
por: Ye, Lei, et al.
Publicado: (2017)

Mouse models and the interpretation of human GWAS in type 2 diabetes and obesity
por: Cox, Roger D., et al.
Publicado: (2011)

Twincretin as a potential therapeutic for the management of type 2 diabetes with obesity
por: Usui, Ryota, et al.
Publicado: (2019)

Posttraumatic Stress Disorder and Incident Type 2 Diabetes: Is Obesity to Blame?
por: Scherrer, Jeffrey F., et al.
Publicado: (2019)

Treatment of vocal fold scarring with autologous bone marrow-derived human mesenchymal stromal cells—first phase I/II human clinical study: commentary to response
por: Hertegård, Stellan, et al.
Publicado: (2020)

Tackling Cardiovascular Risk in Type 2 Diabetes: Does Baseline Glucose Control Matter?
por: Nicholls, Stephen J., et al.
Publicado: (2018)

Commentary on: “Human umbilical cord wharton's jelly-derived mesenchymal stem cell transplantation could improve diabetic intracavernosal pressure”
por: Dimitriadis, Fotios, et al.
Publicado: (2021)

Mesenchymal Stem Cells: A Potential Border Patrol for Transplanted Islets?
por: Brusko, Todd M.
Publicado: (2009)

Effect of honey in diabetes mellitus: matters arising
por: Erejuwa, Omotayo O
Publicado: (2014)

Diabetes in Early Pregnancy: Getting to the Heart of the Matter
por: Gilbert, Jeffrey S., et al.
Publicado: (2013)

Immunomodulatory Functions of Adipose Mesenchymal Stromal/Stem Cell Derived From Donors With Type 2 Diabetes and Obesity on CD4 T Cells
por: Mahmoud, Marwa, et al.
Publicado: (2023)

Pancreatic islet transplantation in type 1 diabetes: Current state and future perspectives
por: Kuo, Chun‐Heng, et al.
Publicado: (2022)

The Intriguing Intersection of Type 2 Diabetes, Obesity-Related Insulin Resistance, and Osteoarthritis
por: Bradley, David
Publicado: (2021)

Mesenchymal stromal cells and leukemia therapy in mice and man
por: Gale, Robert Peter
Publicado: (2020)

Transplantation of insulin-producing cells derived from human mesenchymal stromal/stem cells into diabetic humanized mice
por: Ghoneim, Mohamed A., et al.
Publicado: (2022)

Addressing Biomechanics Matters in Treating Diabetic Foot Ulcers
por: Wukich, Dane K.
Publicado: (2023)

Continuous glucose monitoring targets in type 1 diabetes pregnancy: every 5% time in range matters
por: Murphy, Helen R.
Publicado: (2019)

Persistent Organic Pollutants and Obesity-Related Metabolic Dysfunction: Focusing on Type 2 Diabetes
por: Lee, Duk-Hee
Publicado: (2012)

Socioeconomic Disparities Across the Spectrum of Genetic Burden in Type 2 Diabetes and Obesity Risk
por: Franks, Paul W.
Publicado: (2023)

Therapeutic effects of mesenchymal stem cells on renal ischemia–reperfusion injury: a matter of genetic transfer?
por: Bruno, Stefania, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9m856h76qbejq8js4bvoj9v1qr